Bilaketaren emaitzak - Markus Cornberg

Findu emaitzak
  1. 1
    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity nork Markus Cornberg

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability

    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability nork Markus Cornberg, Frank Tacke, Tom H. Karlsen

    Argitaratua 2018
    Testu osoa Testu osoa
    Editorial
    Gogokoenen artean sartu
    Gorde:
  3. 3
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients nork Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Argitaratua 2021
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Natural killer cells act as rheostats modulating antiviral T cells

    Natural killer cells act as rheostats modulating antiviral T cells nork Stephen N. Waggoner, Markus Cornberg, Liisa K. Selin, Raymond M. Welsh

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference

    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference nork Markus Cornberg, Anna Suk‐Fong Lok, Norah A. Terrault, Fabien Zoulim

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C nork Julia Hengst, Christine S. Falk, Verena Schlaphoff, Katja Deterding, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis

    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis nork Tammo Lambert Tergast, Markus Kimmann, H. Laser, Svetlana Gerbel, Michael P. Manns, Markus Cornberg, Benjamin Maasoumy

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper nork Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Matičič, Elisa Cordero, Markus Cornberg, Thomas Berg

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Private specificities of CD8 T cell responses control patterns of heterologous immunity

    Private specificities of CD8 T cell responses control patterns of heterologous immunity nork Sung-Kwon Kim, Markus Cornberg, Xiaoting Z. Wang, Hong D. Chen, Liisa K. Selin, Raymond M. Welsh

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp>

    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp> nork Katja Deterding, Cheng‐Jian Xu, Kerstin Port, Christopher Dietz‐Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection nork A. Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa‐Breier, J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss nork Christine L. Zimmer, Franziska Rinker, Christoph Höner zu Siederdissen, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Niklas K. Björkström

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity nork Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    EASL Clinical Practice Guidelines on haemochromatosis

    EASL Clinical Practice Guidelines on haemochromatosis nork Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, Bill Griffiths, Edouard Bardou–Jacquet, Elena Corradini, Graça Porto, John Ryan, Markus Cornberg

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection nork Lisa Sandmann, Valerie Ohlendorf, Alena Friederike Ehrenbauer, Birgit Bremer, Anke Kraft, Markus Cornberg, Katja Deterding, Heiner Wedemeyer, Benjamin Maasoumy

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity

    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity nork Liisa K. Selin, Michael A. Brehm, Yuri N. Naumov, Markus Cornberg, Sung‐Kwon Kim, Shalyn C. Clute, Raymond M. Welsh

    Argitaratua 2006
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Treatment of Acute Hepatitis C with Interferon Alfa-2b

    Treatment of Acute Hepatitis C with Interferon Alfa-2b nork Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer, Teresa Santantonio, Julika Mayer, M Zankel, Giuseppe Pastore, Manfred Dietrich, Christian Trautwein, Michael P. Manns

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study

    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study nork Markus Cornberg, Johannes Hadem, Eva Herrmann, Frank Schuppert, Hartmut Schmidt, Markus Reiser, Oliver Marschal, Martín Steffen, Michael P. Manns, Heiner Wedemeyer

    Argitaratua 2005
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort nork Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg, David Back, Heiner Wedemeyer

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhos... nork F Mettke, Bernhard Schlevogt, Katja Deterding, A. Wranke, Andrea Smith, Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: